dc.contributor.author | Averbuch, D. | |
dc.contributor.author | Tridello, G. | |
dc.contributor.author | Hoek, J. | |
dc.contributor.author | Mikulska, M. | |
dc.contributor.author | Pabst, T. | |
dc.contributor.author | Ya?ez San Segundo, L. | |
dc.contributor.author | Cesaro, S. | |
dc.date.accessioned | 2020-12-02T18:00:12Z | |
dc.date.available | 2020-12-02T18:00:12Z | |
dc.date.issued | 2020 | |
dc.identifier.issn | 0163-4453 | |
dc.identifier.uri | https://doi.org/10.1016/j.jinf.2020.11.002 | |
dc.identifier.uri | http://hdl.handle.net/11446/3563 | |
dc.description | PubMed: 33186673 | en_US |
dc.description.abstract | Objectives: We present here data on Gram-negative rods bacteremia (GNRB) rates, risk factors and associated mortality. Methods: Data on GNRB episodes were prospectively collected in 65 allo-/67 auto-HSCT centers in 24 countries (Europe, Asia, Australia). in patients with and without GNRB, we compared: demography, underlying disease, HSCT-related data, center` fluoroquinolone prophylaxis (FQP) policy and accreditation status, and involvement of infection control team (ICT). Results: the GNRB cumulative incidence among 2818 allo-HSCT was: pre-engraftment (pre-eng-allo-HSCT), 8.4 (95% CI 7–9%), post-engraftment (post-eng-allo-HSCT), 5.8% (95%CI: 5–7%); among 3152 auto-HSCT, pre-eng-auto-HSCT, 6.6% (95%CI: 6–7%), post-eng-auto-HSCT, 0.7% (95%CI: 0.4–1.1%). GNRB, especially MDR, was associated with increased mortality. Multivariate analysis revealed the following GNRB risk factors: (a) pre-eng-allo-HSCT: south-eastern Europe center location, underlying diseases not at complete remission, and cord blood source; (b) post-eng-allo-HSCT: center location not in northwestern Europe; underlying non-malignant disease, not providing FQP and never accredited. (c) pre-eng-auto-HSCT: older age, autoimmune and malignant (vs. plasma cell) disease, and ICT absence. Conclusions: Benefit of FQP should be explored in prospective studies. Increased GNRB risk in auto-HSCT patients transplanted for autoimmune diseases is worrying. Infection control and being accredited are possibly protective against bacteremia. GNRB are associated with increased mortality. © 2020 the British Infection Association | en_US |
dc.description.sponsorship | Gilead Sciences Meso Scale Diagnostics, MSD | en_US |
dc.description.sponsorship | HA declares receiving a research grant from MSD; speaker grant from Gilead, MSD, Pfizer. Other co-authors have no conflicts of interest to declare relevant to this study. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | W.B. Saunders Ltd | en_US |
dc.identifier.doi | 10.1016/j.jinf.2020.11.002 | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Bacteremia | en_US |
dc.subject | Fluoroquinolone prophylaxis | en_US |
dc.subject | Gram-negative | en_US |
dc.subject | Mortality | en_US |
dc.subject | Post-engraftment | en_US |
dc.subject | Pre-engraftment | en_US |
dc.subject | Risk factors | en_US |
dc.subject | Stem cell transplantation | en_US |
dc.title | Intercontinental study on pre-engraftment and post-engraftment Gram-negative rods bacteremia in hematopoietic stem cell transplantation patients: Risk factors and association with mortality | en_US |
dc.type | article | en_US |
dc.relation.journal | Journal of Infection | en_US |
dc.department | DBÜ | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.department-temp | Averbuch, D., Hadassah University Hospital, Jerusalem, Israel; Tridello, G., Pediatric Hematology Oncology, Mother and Child Hospital, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy; Hoek, J., EBMT Data Office, Leiden, Netherlands; Mikulska, M., Division of Infectious Diseases, University of Genoa and Ospedale Policlinico San Martino, Genova, Italy; Pabst, T., Department of Medical Oncology, University Hospital Bern, Bern, Switzerland; Ya?ez San Segundo, L., Hospital U. Marqués de Valdecilla, Santander, Spain; Akan, H., Ankara University Faculty of Medicine, Ankara, Turkey; Özçelik, T., Bilim University, Florence Nightingale Hospital, Istanbul, Turkey; Donnini, I., Azienda Ospedaliera Universitaria Careggi, Firenze, Italy; Klyasova, G., National Research Center for | en_US |